Evaluation of porphyria

Photodermatology Photoimmunology and Photomedicine

Volumn 14, Issue 2, 1998, Pages 58-63

  Murphy, G M ^a,b  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b BEAUMONT HOSPITAL   (Ireland)

Author keywords

Phototoxicity; Porphyria

Indexed keywords

ANTIHISTAMINIC AGENT; BETA CAROTENE; CHARCOAL; CHLOROQUINE; COLESTYRAMINE; COPROPORPHYRINOGEN OXIDASE; CYSTEINE; FERROCHELATASE; GONADORELIN AGONIST; HEME ARGINATE; PORPHOBILINOGEN DEAMINASE; PORPHOBILINOGEN SYNTHASE; PROTOPORPHYRIN TIN; PSORALEN; UROPORPHYRINOGEN DECARBOXYLASE; UROPORPHYRINOGEN III SYNTHASE;

BONE MARROW TRANSPLANTATION; CLINICAL FEATURE; CONGENITAL ERYTHROPOIETIC PORPHYRIA; DISEASE CLASSIFICATION; ERYTHROPOIETIC PROTOPORPHYRIA; GENETIC COUNSELING; HUMAN; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHOTOTOXICITY; PORPHYRIA; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; REVIEW; SPLENECTOMY;

EID: 0031864694     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0781.1998.tb00012.x     Document Type: Review

References (52)

1. Gibbs NK, Traynor N, Ferguson J. Biochemical diagnosis of the cutaneous porphyrias. five years experience of plasma spectro-fluorimetry. Br J Dermatol 1995: 133: 18s.
2. Doss M, Tiepermann RV, Schneider J et al. New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestations. Klin Wochenschr 1970: 57: 1123-1127.
3. Lim HW, Murphy GM. The porphyrias. Clin Dermatol 1996: 14: 375-387.
4. Murphy GM. The cutaneous porphyrias. A review of diagnosis and management. J Eur Acad Dermatovenereol 1993: 2: 11-17.
5. Siersma PD, Rademakers LH, Cleton MI et al. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron. J Hepatol 1995: 23: 259-267.
6. Roberts AG, Whatley SD, Nicklin S et al The frequency of hemochromatosis-associated alleles is increased in British patients with sporadic porphyria cutanea tarda. Hepatology 1997: 25: 159-161.
7. O'Reilly FM, Darby C, Fogarty J et al. Screening of patients with iron overload to identify haemochromatosis and porphyria cutanea tarda. Arch Dermatol 1997: 133: 1098-1101.
8. Boffa MJ, Reed P, Weinkove C, Ead RD. Hypertrichosis as the presenting feature of porphyria cutanea tarda. Clin Exp Dermatol 1995: 20: 62-64.
9. Castanet J, Lacour JP, Perrin C, Guidoni JF, Ortonne JP. Sclerodermatous changes revealing porphyria cutanea tarda. Acta Derm Venereol 1994: 74: 310-311.
10. Adams PC, Powell LW. Porphyria cutanea tarda and HLA-linked haemochromatosis - all in the family? Gastroenterology 1987: 92: 2033-2035.
11. Murphy A, Dooly S, Hillary IB, Murphy GM. HCV infection in porphyria cutanea tarda. Lancet 1993: 341: 1534-1535.
12. Lacour JP, Bodokh I, Castanet J, Bekri S, Ortonne JP. Porphyria cutanea tarda and antibodies to hepatitis C virus. Br J Dermatol 1993: 128: 121-123.
13. Connor WJ, Murphy GM, Darby C et al. Porphyrin abnormalities in acquired immune deficiency syndrome. Arch Dermatol 1996: 132: 1443-1447.
14. Burnett JW, Lamon JM, Levin J. Haemophilia, hepatitis and porphyria. Br J Dermatol 1977: 97: 453-455.
15. Guyotat D, Nicolas JF, Augey F, Fiere D, Thivolet J. Porphyria cutanea tarda after bone marrow transplantation for chronic myelogenous leukaemia. Am J Haematol 1990: 34: 69-70.
16. O'Reilly FM, O'Loughlin S, Murphy GM. Discoid lupus erythematosus and porphyria cutanea tarda. J R Soc Med 1996: 89: 523-524.
17. McKenna D, Browne M, O'Donnell R, Murphy GM. Porphyria cutanea tarda and hematologic malignancy a report of 4 cases. Photoderm Photoimmunol Photomed 1997: 13: 143-146.
18. Robertson AG, Elder GH, Newcombe RG et al. Heterogeneity of familial porphyria cutanea tarda. J Med Genet 1988: 25: 669-676.
19. Roberts AG, Elder GH, De Salamanca et al. A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients. J Invest Dermatol 1995: 104: 500-502.
20. Ramsay CA, Magnus IA, Turnbull A et al. The treatment of porphyria cutanea tarda by venesection. QJM 1974: 43: 1-24.
21. Ashton RE, Hawk JLM, Magnus IA. Low dose chloroquine in the treatment of porphyria cutana tarda. Br J Dermatol 1981: 111: 609-613.
22. Sarkell B, Patterson JW. Treatment of porphyria cutanea tarda of end stage renal failure with erythropoietin. J Am Acad Dermatol 1993: 29: 499-500.
23. Okano J, Horie Y, Kawasaki H, Kondo M. Interferon treatment of porphyria cutanea tarda associated with chronic hepatitis type C Hepatogastroenterology 1997: 44: 525-528.
24. Murphy GM, Hawk JLM, Corbett MF, Magnus IA. The UK erythropoictic protoporphyria register. Br J Dermatol 1985: 113 (Suppl 29): 11.
25. Mion FB, Faure JL, Berger F et al. Liver transplantation for erythropoietic protoporphyria. Report of a new case with subsequent medium-term follow-up. J Hepatol 1992: 16: 203-207.
26. Bonkowsky HL, Schned AR. Fatal liver failure in protoporphyria. Synergism between ethanol excess and the genetic defect. Gastroenterol 1986: 90: 191-201.
27. Rademakers LH, Koningsberger JC, Sorber CW, Bart de la Faille H, Van-hattum J, Marx JJ. Accumulation of iron in erythroblasts of patients with erythropoietic protoporphyria. Eur J Clin Invest 1993: 23: 130-138
28. Meerman L, Verwer R, Slooff MJ et al. Perioperative measures during liver transplantation for erythropoietic protoporphyria. Transplantation 1994: 57: 155-158.
29. De Leo VA, Poh-Fitzpatrick MB, Matthews-Roth MM et al. Erythropoietic protoporphyria: ten years of experience. Am J Med 1976: 60: 8-22.
30. Mathews-Roth MM, Kosner B, Renfell K, Roberts JK. A double-blind study of cysteine photoprotection in erythropoietic protoporphyria. Photoderm Photoimmunol Photomed 1994: 10: 244-248.
31. Norris PG, Baker CS, Roberts JE, Hawk JL. Treatment of erythropoietic protoporphyria with N-acetylcysteine. Arch Dermatol 1995: 131: 354-355.
32. Collins P, Ferguson J. Narrow band UVB (TL-O1) phototherapy: an effective preventative treatment for the photodermatoses. Br J Dermatol 1995: 132: 963-965.
33. Farr PM, Diffey BL, Matthew N. Inhibition of photosensitivity in erythropoietic protoporphyria with terfenadine. Br J Dermatol 1990: 122: 809-815.
34. McCullough AJ, Barron D, Mullen KD et al. Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feeding. Gastroenterology 1988: 94: 177-181.
35. Murphy GM, Hawk JLM, Nicholson DC et al. Congenital erythropoietic porphyria (Günther's disease). Clin Exp Dermatol 1987: 12: 61-65.
36. MacDonald A, Nicholson D, Williams R. Late onset erythropoietic uroporphyria. Br J Dermatol 1976: 95: 30s-33s.
37. Murphy A, Gibson G, Elder GH, Otridge BA, Murphy GM. Adult-onset congenital erythropoietic porphyria (Günther's disease) presenting with thrombocytopenia. J R Soc Med 1995: 88: 357-358.
38. Tishler PV, Winston SH. Rapid improvement in the chemical pathology of congenital erythropoietic protoporphyria with treatment with super activated charcoal. Methods Find Exp Clin Pharmacol 1990: 12: 645-648.
39. Kauffman L, Evans DIK, Stevens RF, Weinkove C. Bone marrow transplantation for congenital erythropoietic porphyria. Lancet 1991: 337: 1510-1511.
40. Zix-Kieffer I, Langer B, Eyer D et al. Successful cord blood stem cell transplantation for congenital erythropoietic porphyria (Günther's disease). Bone Marrow Transplant 1996: 18: 217-220.
41. Ged C, Moreau-Gaudry F, Taine L et al. Prenatal diagnosis in congenital erythropoietic porphyria by metabolic measurement and DNA mutation analysis. Prenatal Diagnosis 1996: 16: 83-86.
42. British National Formulary. Brit Med Assoc & Roy Pharmaceut Soc Grt Brit 1997: 34: 416-417.
43. Mustajoki P, Nordmann Y. Early administration of heme arginate for acute porphyric attacks. Arch Int Med 1993: 153: 2004-2008.
44. Herrick AL, McColl KE, Wallace AM, Moore MR, Goldberg A. A LHRH analogue treatment for the prevention of premenstrual attacks of acute porphyria. QJM 1990: 75: 355-363.
45. Dover SB, Moore MR, Fitzsimmons EJ, Graham A, McColl KE. Tin protoporphyrin prolongs the biochemical remission produced by heme arginate in acute hepatic porphyria. Gastroenterology 1993: 105: 590-594.
46. Poh-Fitzpatrick MB. A plasma porphyrin fluorescence marker for variegate porphyria. Arch Dermatol 1980: 116: 543-547.
47. Long C, Smyth SJ, Woolf J et al. Detection of latent variegate porphyria by fluorescence emission spectroscopy of plasma. Br J Dermatol 1993: 129: 9-13.
48. Kordaç V, Martesed P, Zeman J et al. Increased erythrocyte protoporphyrin in homozygous variegate porphyria. Photodermatol 1985: 2: 257-259.
49. Murphy GM, Hawk JLM, Magus IA, Barrett DF, Elder GH, Smith SG. Homozygous variegate porphyria: two similar cases in unrelated families. J R Soc Med 1986: 79: 361-363.
50. Grandchamp B, Phung N, Nordmann Y. Homozygous case of hereditary coproporphyria. Lancet 1977: ii: 1348-1349.
51. Sarkany RPE, Alexander GJMA, Cox TM. Recessive inheritance of erythropoietic protoporphyria with liver failure. Lancet 1994: 343: 1394-1396.
52. Xu W, Warner CA, Desnick RJ. Congenital erythropoietic porphyria: identification and expression of 10 mutations in the uroporphyrinogen III synthase gene. J Clin Invest 1995: 95: 905-912.